Marché mondial des dispositifs de biopsie intelligents – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse du marché et perspectives du marché des dispositifs de biopsie intelligents

Selon les analyses de Data Bridge Market Research, le marché des dispositifs de biopsie intelligents devrait connaître un TCAC d'environ 6,12 % pour la période de prévision 2022-2029. La demande croissante de procédures chirurgicales mini-invasives, l'accent accru mis sur les compétences en recherche et développement en matière de dispositifs médicaux et sur l'adoption de technologies de santé informatiques avancées , l'augmentation des cas de cancer dans le monde et l'augmentation des dépenses pour le développement des infrastructures de santé, en particulier dans les économies en développement, sont les principaux facteurs attribuables à la croissance du marché des dispositifs de biopsie intelligents.

La biopsie est un examen médical utilisé pour diagnostiquer le cancer chez les patients. La biopsie consiste en l'extraction chirurgicale de tissu à des fins d'examen et de diagnostic. Les dispositifs de biopsie intelligents sont des dispositifs médicaux qui facilitent la différenciation de haute qualité des cellules saines et des cellules tumorales.  

L'augmentation du financement public-privé pour  les activités de recherche ciblées  , associée à une sensibilisation accrue aux avantages offerts par les appareils de biopsie intelligents, est l'un des principaux facteurs favorisant la croissance du marché. Les avancées technologiques et le développement croissants dans le domaine de la robotique sont un autre déterminant de la croissance du marché. Les progrès technologiques et l'innovation sans cesse croissants de nouveaux dispositifs et instruments médicaux, le nombre croissant de lancements de produits, le soutien croissant du gouvernement aux activités de recherche, la prévalence croissante du cancer du sein, le mode de vie malsain des individus, l'augmentation des cas de cancer du col de l'utérus chez les femmes et l'augmentation du financement gouvernemental et le potentiel inexploité des marchés émergents généreront davantage d'opportunités de croissance lucratives du marché.

However, high costs associated with biopsy medical test and lack of skilled medical professionals will derail the market growth rate. Also, lack of awareness in the underdeveloped and backward economies and high expenditure required for research and development activities will further pose challenges for the market. High risk of infection and rising number of product recalls will further derail the market growth rate.

This smart biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on smart biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Smart Biopsy Devices Market Scope and Market Size

The smart biopsy devices market is segmented on the basis of application, product, guidance technique and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on application, the smart biopsy devices market is segmented into breast cancer, skin cancer, liver cancer, prostate cancer, and others.
• On the basis of product, the smart biopsy devices market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products. Needle-based biopsy instruments are further segmented into core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, localization wires, procedure trays, and others. Core biopsy devices are further sub-segmented into core biopsy guns and core biopsy needles. Vacuum-assisted biopsy devices are further sub-segmented into vacuum-assisted biopsy systems and vacuum-assisted biopsy needles.
• On the basis of guidance technique, the smart biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and other guidance techniques.
• On the basis of end user, the smart biopsy devices market is segmented into hospitals, academic and research institutes, and diagnostic and imaging centers.

Smart Biopsy Devices Market Country Level Analysis

The smart biopsy devices market is segmented on the basis of application, product, guidance technique and end-user.

The countries covered in the smart biopsy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the smart biopsy devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies and presence of major players in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector and increasing cases of breast cancer in the region.   

The country section of the smart biopsy devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The smart biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for smart biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart biopsy devices market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Smart Biopsy Devices Market Share Analysis

The smart biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to smart biopsy devices market.

Français Certains des principaux acteurs opérant dans le rapport sur le marché des dispositifs de biopsie intelligents sont BD, Cook, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, Scion Medical Technologies, LLC, UROMED Kurt Drews KG, STERYLAB Srl, DTR Medical Ltd, EndoMed Systems Tous droits réservés., CONMED Corporation, TSK Laboratory Europe BV, ZAMAR CARE, B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic et SRL Diagnostics, entre autres.

SKU-50549